Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neurogenic vision loss: Causes and outcome. An experience from a tertiary center in Northern India.
Autoimmune Demyelinating Polyneuropathy as a Manifestation of Chronic Graft-versus-Host Disease after Adult Cord Blood Transplantation in a Patient with Chronic Lymphocytic Leukemia.
Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.
GM-CSF promotes migration of human monocytes across the blood brain barrier.
The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients.
Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis?
Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - NO.
Illuminating vitamin D effects on B-cells - the multiple sclerosis perspective.
Comprehensive Profile of Cardiopulmonary Exercise Testing in Ambulatory Persons with Multiple Sclerosis.
[Antidepressants for treatment of depression in palliative patients : A systematic literature review.]
Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases.
Immunoglobulin GM allotypes in multiple sclerosis.
Validity of visual perceptive computing for static posturography in patients with multiple sclerosis.
Microenvironmental Regulation of Oligodendrocyte Replacement and Remyelination in Spinal Cord Injury.
Comments on "Role of intestinal microbiota in the development of multiple sclerosis".
Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 Years.
Association between Smoking and Health Outcomes in Postmenopausal Women Living with Multiple Sclerosis.
Estimation of the multiple sclerosis risk in population living on contaminated territories after the Chornobyl catastrophe.
PD-1 Interaction with PD-L1 but not PD-L2 on B-cells Mediates Protective Effects of Estrogen against EAE.
Intramedullary spinal cord metastasis from salivary ductal carcinoma of the parotid gland mimicking transverse myelitis in a patient with radiologically isolated syndrome.
Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease.
Comparison of 3D Cube FLAIR with 2D FLAIR for Multiple Sclerosis Imaging at 3 Tesla.
Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination.
Clinico-radiologic profile of spinal cord multiple sclerosis in adults.
PGE2/EP4 signaling in peripheral immune cells promotes development of experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
557
558
559
560
561
562
563
564
565
…
next ›
last »